Dr Reddys Laboratories (RDY) Capital Leases (2021 - 2026)

Dr Reddys Laboratories has reported Capital Leases for 6 years, with the latest figure at $7.4 million in Q1 2026.

• On a quarterly basis, Capital Leases rose 108.16% year-over-year to $7.4 million in Q1 2026; TTM through Mar 2026 was $7.4 million, a 108.16% increase from a year earlier, with the FY2026 full-year figure at $7.7 million, up 110.42% from the prior year.
• Capital Leases was $7.4 million for Q1 2026 at Dr Reddys Laboratories, up from $3.6 million in the prior quarter.
• The five-year high for Capital Leases was $7.4 million in Q1 2026, with the low at $1.9 million in Q1 2022.
• Average Capital Leases over 5 years is $4.0 million, with a median of $3.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Capital Leases plunged 83.61% in 2022, then jumped 108.16% in 2026.
• Over 5 years, Capital Leases stood at $1.9 million in 2022, then soared by 123.66% to $4.3 million in 2023, then retreated by 7.39% to $4.0 million in 2024, then slipped by 11.28% to $3.6 million in 2025, then jumped by 108.16% to $7.4 million in 2026.
• The last three Capital Leases figures came in at $7.4 million (Q1 2026), $3.6 million (Q1 2025), and $4.0 million (Q1 2024), per Business Quant data.